Lawmakers Agree to Ban on Patents for Human Organisms

Law360, New York (November 24, 2003, 12:00 AM EST) -- U.S. lawmakers agreed Monday to a controversial provision in a spending bill to bar the U.S. Patent Office from issuing patents on human organisms, such as genetically engineered embryos.

The provision will codify existing Patent Office rules that human organisms are not patentable subject matter and will not interfere with stem cell research, according to Rep. Dave Weldon, R-Fla., who sponsored the bill.

The provision would ban patents for genetically engineered human embryos, fetuses and human beings, but would not affect patents on genes, cells, tissue...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.